BAT1706

Sandoz in oncology biosimilar deal with China’s Bio-Thera
Biopharma Reporter
Wed, 09/8/21 - 11:15 am
Sandoz
Novartis
biosimilars
China
BAT1706
Bio-Thera Solutions
Bio-Thera Solutions announces positive top-line results for BAT1706, a proposed biosimilar to Avastin
Pharmaceutical Business Review
Tue, 02/4/20 - 10:05 am
BAT1706
Bio-Thera Solutions
Avastin
Roche
non-squamous non-small cell lung cancer
biosimilars